IVF outcomes after transvaginal sclerotherapy for ovarian endometrioma: a systematic review and meta-analysis
Systematic review / meta-analysis
OA: closed
CC0
AI-generated summary
This systematic review and meta-analysis evaluated in vitro fertilization outcomes following transvaginal sclerotherapy for ovarian endometrioma.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To evaluate whether pre-IVF/ICSI transvaginal ethanol sclerotherapy for ovarian endometrioma improves reproductive outcomes compared with expectant management, and to assess whether prior cystectomy modifies treatment effect.
DATA SOURCES: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, major clinical trial registries, PubMed, and Google Scholar were searched from 1980 to November 2025 without language restriction.
METHODS OF STUDY SELECTION: Eligible studies included women with ovarian endometrioma undergoing IVF/ICSI, comparing those who received sclerotherapy with those managed expectantly. Eligible study designs included randomized controlled trials (RCTs) and observational cohorts. Following the screening of 742 records, six studies met the inclusion criteria: one RCT, one prospective comparative study, and four retrospective cohorts.
RESULTS: Six studies (one RCT, four retrospective cohorts, and one prospective comparative study) were included. The primary patient-level live birth analysis (2 studies, 124 patients) showed no statistically significant difference between sclerotherapy and expectant management (OR 2.20, 95% CI 0.66-7.32, p=0.20). The primary patient-level analysis for clinical pregnancy (4 studies, 221 patients) demonstrated that sclerotherapy was associated with a significantly higher clinical pregnancy rate (OR 2.14, 95% CI 1.21-3.79, p=0.009). At the cycle level, sclerotherapy yielded significantly more total oocytes (MD 2.20, 95% CI 0.06-4.34, p=0.04) and total embryos (MD 0.56, 95% CI 0.07-1.05, p=0.02), whereas the increase in mature oocytes was non-significant (MD 1.56, 95% CI -0.14-3.26, p=0.07). According to the GRADE framework, the certainty of evidence for all outcomes was Very Low.
CONCLUSION: Low-certainty evidence suggests that pre-IVF ethanol sclerotherapy for ovarian endometrioma may be associated with improved clinical pregnancy compared with expectant management, with benefits evident regardless of prior cystectomy history. While a positive trend in live births was observed, this finding was not statistically significant at the patient level, highlighting the fragility of the current evidence. These clinical enhancements are supported by overall improvements in oocyte and embryo yields. Sclerotherapy serves as a valuable, fertility-preserving alternative to repeat surgery for selected patients.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (26)
- Assisted reproductive technique outcomes in patients with endometrioma undergoing sclerotherapy vs laparoscopic cystectomy: Prospective cross-sectional study via openalex
- A systematic review of ultrasonography-guided transvaginal aspiration of recurrent ovarian endometrioma via openalex
- Can the endometrioma be an obstacle to complete oocyte retrieval in IVF cycles? A retrospective study via openalex
- Effect of laparoscopic cystectomy on ovarian reserve in patients with ovarian cyst via openalex
- Efficacy of Ethanol Sclerotherapy Versus Laparoscopic Excision in the Treatment of Ovarian Endometrioma via openalex
- Endometriosis via openalex
- Ethanol Sclerotherapy versus Laparoscopic Surgery for Endometrioma Treatment: A Prospective, Multicenter, Cohort Pilot Study via openalex
- Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis via openalex
- In situ methotrexate injection for treatment of recurrent endometriotic cysts via openalex
- Management of transvaginal ultrasound-guided absolute ethanol sclerotherapy for ovarian endometriotic cysts via openalex
- Ovarian reserve and IVF outcomes after ethanol ovarian sclerotherapy in women with endometrioma: a systematic review and meta-analysis via openalex
- Pretreatment for ovarian endometrial cyst before in vitro fertilization via openalex
- Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis via openalex
- The Efficacy and Safety of Transvaginal Ethanol Sclerotherapy in the Treatment of Endometrial Cysts-A Systematic Review via openalex
- The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis via openalex
- The impact of laparoscopic cystectomy on ovarian reserve in patients with unilateral and bilateral endometrioma via openalex
- Transvaginal ethanol sclerotherapy for an endometrioma in 10 steps via openalex
- W4211081176 via openalex
- W4386627490 via openalex
- W2970684805 via openalex
- W2796625897 via openalex
- W4391649863 via openalex
- W2137020199 via openalex
- W2118598742 via openalex
- W4214754424 via openalex
- W4409140437 via openalex
Source provenance
- europepmc
- last seen: 2026-11-22T09:57:54.571072+00:00
- openalex
- last seen: 2026-11-22T06:06:27.128750+00:00
- pubmed
- last seen: 2026-11-22T06:08:19.120011+00:00
License: CC0
· commercial use OK